HealthTree

Your Feed

Filter by

See content from

Back to the latest

Thumbnail for How and why should I obtain a second opinion?

Playlist: Building Your Healthcare Team

How and why should I obtain a second opinion?

Video details & playlist

Medicare and Medicaid Increases CAR T Coverage for Multiple Myeloma Treatment

Medicare and Medicaid Increases CAR T Coverage for Multiple Myeloma Treatment image

There's a New Kid In Town: Dr. William Matsui Develops New Multiple Myeloma Research Program in Austin, Texas

There's a New Kid In Town: Dr. William Matsui Develops New Multiple Myeloma Research Program in Austin, Texas image

Using Selinexor in Today's Myeloma Clinic with Paul Richardson, MD, Dana Farber Cancer Institute

Using Selinexor in Today's Myeloma Clinic with Paul Richardson, MD, Dana Farber Cancer Institute

Using Selinexor in Today's Myeloma Clinic with Paul Richardson, MD, Dana Farber Cancer Institute image

Listen to episode

New Study Helps Researchers Determine Which MGUS Patients Develop Multiple Myeloma

New Study Helps Researchers Determine Which MGUS Patients Develop Multiple Myeloma image

Thumbnail for Is my family at risk of developing myeloma?

Playlist: Multiple Myeloma Basics Part 3

Is my family at risk of developing myeloma?

Video details & playlist

Multiple Myeloma Side Effects: Neuropathy

Multiple Myeloma Side Effects: Neuropathy image

New Tool to Predict And Prevent Blood Clots in Multiple Myeloma Patients

New Tool to Predict And Prevent Blood Clots in Multiple Myeloma Patients image

First Myeloma Patient Receives New Bi-Specific Antibody (BiTE) by Teneobio and Abbvie

First Myeloma Patient Receives New Bi-Specific Antibody (BiTE) by Teneobio and Abbvie image

Thumbnail for Why should an individual get a second opinion before choosing a treatment option?

Playlist: Multiple Myeloma Basics Part 3

Why should an individual get a second opinion before choosing a treatment option?

Video details & playlist

The Mind Game of Multiple Myeloma

The Mind Game of Multiple Myeloma image

Thumbnail for What should a myeloma patient consider when choosing a treatment option?

Playlist: Multiple Myeloma Basics Part 3

What should a myeloma patient consider when choosing a treatment option?

Video details & playlist

Thumbnail for How prevalent is myeloma in the US?

Playlist: Multiple Myeloma Basics Part 3

How prevalent is myeloma in the US?

Video details & playlist

Thumbnail for How is a line of therapy defined?

Playlist: Multiple Myeloma Basics Part 3

How is a line of therapy defined?

Video details & playlist

Thumbnail for What are the risk factors for developing myeloma?

Playlist: Multiple Myeloma Basics Part 3

What are the risk factors for developing myeloma?

Video details & playlist

FDA Lifts Hold on CANOVA Venetoclax Trial in Myeloma

FDA Lifts Hold on CANOVA Venetoclax Trial in Myeloma image

Early Indications of Potential Heart Conditions Using Carfilzomib in Multiple Myeloma

Early Indications of Potential Heart Conditions Using Carfilzomib in Multiple Myeloma image

ASCO 2019: A New Cereblon Inhibitor for Multiple Myeloma

ASCO 2019: A New Cereblon Inhibitor for Multiple Myeloma image

ASCO 2019: New Updates in Smoldering Myeloma

ASCO 2019: New Updates in Smoldering Myeloma image

Patient Power: Getting Good Nutrition When You Don't Feel Like Eating

Patient Power: Getting Good Nutrition When You Don't Feel Like Eating image

Blood Cancer Patients at Greater Risk for Head and Neck Cancers

Blood Cancer Patients at Greater Risk for Head and Neck Cancers image

New Proteasome Inhibitor to Treat Multiple Myeloma

New Proteasome Inhibitor to Treat Multiple Myeloma image

Myeloma Immunotherapy in Review with Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center

Learn more in this overview show with immunotherapy expert Dr. Alexander Lesokhin as he shares more about every type of immunotherapy being used in myeloma care

Myeloma Immunotherapy in Review with Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center image

Listen to episode

Clinical Trial: Daratumumab, Ixazomib, and Dexamethasone With or Without Bortezomib in Patients With Newly Diagnosed Multiple Myeloma (DeRIVE)

Clinical Trial: Daratumumab, Ixazomib, and Dexamethasone With or Without Bortezomib in Patients With Newly Diagnosed Multiple Myeloma (DeRIVE) image

More from HealthTree